Health Economics and Outcomes Research Conference
Virtual Conference | On demand
Price: Members-in-Training $39; Members $89; Nonmembers $129
Health economic evaluation data and patient-reported outcome measurements are necessary to translate research into viable treatment options. Will your data be meaningful to industry, to payers, to regulators? Considering these factors early in the research design will set you up for success. Learn the fundamentals and how to apply them now.
After attending this conference, participants will be able to:
• Discuss the fundamental principles of health economic (HE) evaluation and the measurement of patient-reported outcomes (PROMs)
• Explain the results of HE evaluations and PROMs published in peer-reviewed literature
• Identify a well-formulated HEOR research question and the data needed to answer it
• Describe the design and execution of several HE evaluation and PROMs research projects
• Summarize how patients can contribute to the research design process
*Certificate available in ARVOLearn upon completion of the on-demand conference.
Agenda
Opening keynote: Why does Health Economics and Outcomes Research (HEOR) Matter?
- Conference welcome — ARVO President Maureen G. Maguire, PhD, FARVO
- Introduction to the conference — Andrew F. Smith, PhD, MSc
- Introduction of keynote speaker — Kevin D. Frick, PhD
- Keynote: Why Does Health Economics and Outcomes Research (HEOR) Matter? — Dennis P. Scanlon, PhD
- Discussion with Dennis P. Scanlon, PhD
Fundamentals of patient reported outcomes research
- Perspective matters: How differences in perspectives impact Patient Reported Outcome Measures (PROMs) — Bonnielin Swenor, PhD, MPH
- The science of PRO Measurement — Vijaya K. Gothwal, PhD
- Patient-Reported Outcome Measures for ophthalmic diseases and disorders — David C. Musch, PhD, MPH, FARVO
- Linguistic validation: A necessity for global PRO research — João Pedro Marques, MD, MSc, FEBO
- Introduction to Health Economics and its intersection with Patient-Reported Outcome Measurements (PROMs) — Jyoti Khadka, PhD, MPhil
- Discussion with presenters
Fundamentals of HEOR
- How to identify, measure and value costs — Andrew F. Smith, PhD, MSc
- How to quantify and value benefits: Utility measurements — Kevin D. Frick, PhD
- Ways that data can be brought together for a health economic evaluation — Kevin D. Frick, PhD
- How to critically appraise a study — Kevin D. Frick, PhD
- How to select the appropriate health economic evaluation tool and/or technique — Andrew F. Smith, PhD, MSc
- Useful data sources for health economic analyses — Andrew F. Smith, PhD, MSc
- Discussion with presenters
Panel discussion: Formulating HEOR questions
- Tasanee Braithwaite, BMBCh, MPH, DM
- Lisa Keay, PhD, MPH, B (Optom)
- David B. Rein, PhD
- Kevin D. Frick, PhD (Moderator)
HEOR case studies
- The economic burden of vision loss and blindness in the United States — David B. Rein, PhD
- Cost-utility analysis and ophthalmic interventions — Melissa M. Brown, MD, MN, MBA
- Cost-effectiveness of a national diabetic retinopathy screening program in Singapore — Ecosse Lamoureux, PhD, MSc
- The health economics of diabetic retinopathy screening in the United Kingdom: From opportunistic to systemic to a risk-based (personalized) approach — Marilyn James, PhD
- Non-infectious inflammatory eye disease (NIIED) in a commercially-insured population in the United States — Thomas Arno Albini, MD
Patient-reported outcomes research case studies
- Outcomes that matter to patients with Dry Eye — Ian J. Saldanha, MBBS, MPH, PhD
- Patient-reported outcomes of corneal cross-linking for keratoconus: A Save Sight Keratoconus Registry study — Himal Kandel, PhD, MSc, PHEC
- Case studies in patient-reported outcome measures for vision impairment — Joshua R Ehrlich, MD, MPH
- Visual functioning outcomes following cataract surgery: An item bank approach — Vijaya K. Gothwal, PhD
- Michigan retinal degeneration questionnaire — Maria Fernanda Abalem, MD, MSc, PhD
- Estimating utility in epidemiological eye surveys: Insights from NESTT — Tasanee Braithwaite, BMBCh, MPH, DM
Industry perspectives on HEOR
- Representatives from Gensight Biologics, Janssen Retina, Aerie Pharmaceuticals and independent consulting firm, NCEBiotech LLC, come together to review the dynamics and type of data required to help ophthalmic drugs and devices enter the global marketplace
- Eric Nelson, PhD; Julio Benedicto; H. Nida Sen, MD, MHS; Michelle Senchyna, PhD; Andrew F. Smith, PhD,MSc
Regulatory perspectives on HEOR
- Exploring HEOR questions can be more impactful when the answers provide data that matter to government agencies and regulators. Representatives from the U.S. FDA, Ophthalmic Devices Division, the Patented Medicine Prices Review Board of Canada, and the Pharmaceutical Benefits Scheme (PBS) of Australia will talk about the data examined by their agencies
- Fraser Bocell, MEd, PhD; Mitchell Levine, MD, MSc, FRCPC, FACP, FISPE; Sarah Norris, PhD; Tieuvi Nguyen, PhD; Kevin D. Frick, PhD; Christopher McCabe, PhD
Closing keynote: Eyes toward engagement - A patient perspective on partnered research
- Welcome and introduction of keynote speaker — Kevin D. Frick, PhD
- Closing keynote — Rachel Dungan, MSSP
- Discussion with Rachel Dungan, MSSP
Keeping the patients in mind when designing experiments
- Why patient-centered approaches and early patient involvement in project planning is important in outcomes research — Helen Baker, PhD
- Patient and public involvement in PROMs and health economics — Orla Gavin, PhD
- DREAMing for patients — Penny Asbell, MD, FACS, MBA, FARVO
Ask the experts: Applying the concepts to your research project
-
Can’t miss this session. Conference planners, speakers and panelists answer questions specific to attendees’ research projects. Leave this session with concrete advice to implement now.
-
Helen Baker, PhD; Lisa Keay, PhD, MPH; Kevin D. Frick, PhD; Penny Asbell, MD, FACS, MBA, FARVO; Andrew F. Smith, PhD, MSc
-